Revolution Medicines Financial Overview
Revolution Medicines's market cap is currently $14.84B. The company's EPS TTM is $-1.61; its P/E ratio is -14.66; Revolution Medicines is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-1.59. See an overview of income statement, balance sheet, and cash flow financials.
